Hafnia alvei is a gram-negative bacterium that is rarely isolated from human specimens and is rarely considered to be pathogenic. It has been associated with gastroenteritis, meningitis, bacteremia, pneumonia, nosocomial wound infections, endophthalmitis, and a buttock abscess. We studied 80 H. alvei isolates recovered from 61 patients within a period of 30 months. H. alvei was cultured from sites that included the respiratory tract (n = 38), the gastrointestinal tract (n = 16), and the urogenital tract (n = 12); the organism was found in blood cultures (n = 8), on central venous catheters (n = 3), and on the skin (n = 3). Only 25% of H. alvei isolates were recovered in pure cultures. Fifty-seven (93.4%) of the patients had an underlying illness. H. alvei proved to be the etiologic agent in two episodes of septicemia and in one episode of peritonitis and was probably responsible for septicemia in two other patients and pneumonia in one. All six of these patients recovered after receiving antibiotic treatment and/or standard surgical treatment, when needed. Three of these infections were nosocomial, and three were community acquired. Of the strains of H. alvei tested in our study, 100% were susceptible to netilmicin, ciprofloxacin, and imipenem; 92% were susceptible to piperacillin; 90% were susceptible to co-trimoxazole; and 88% were susceptible to ceftriaxone and ceftazidime. In this study, we found H. alvei to be a rare but significant etiologic agent of nosocomial and community-acquired infections.
Hafnia alvei is a gram-negative facultative rod-shaped anaerobe that belongs to the Enterobacteriaceae; the organism was formerly named Enterobacter hafniae. H. alvei is rarely considered to be pathogenic; rather, H alvei has been found to be related to the enteropathogenic Escherichia coli on the basis of a single virulence factor. Electron microscopy has demonstrated inflammation and mucosal invasion by H alvei in rabbit bowels, and an attachment-effacement gene like that detected in enteropathogenic E. coli was found in H. alvei by hybridization [1, 2] . No other distinct virulence factors have been noted in this organism so far [3] . Stool specimens are generally not examined for the presence of H alvei. Cases of diarrhea due to H alvei have occurred mainly in children. H. alvei was reported to have caused acute gastroenteritis in children from Bangladesh and Spain [1] [2] . In one study, 16% of Finnish tourists with acute gastroenteritis and diarrhea who were returning from Morocco excreted H alvei in their stools [4] . Seven strains isolated from children with diarrhea expressed the attachment-effacement gene [2] . In two case reports, H alvei was mentioned as a cause of nonbloody diarrhea. One of these cases was presumably associated with reactive arthritis [5, 6] ; however, cultures of joint aspirates were negative. A single case of H alvei meningitis in a 1-year-old girl [7] and a case of necrotizing H alvei enterocolitis with septicemia in a 20-day-old boy [8] have also been described. In adults, H alvei has caused bacteremia [9, 10] , pneumonia, and nosocomial wound infections [11] [12] [13] . H. alvei was recovered with Salmonella arizonae from a patient with endogenous endophthalmitis who was receiving steroids [14] . Recently, H alvei was isolated from a buttock abscess that resulted from skin puncture with carpet nails in an otherwise healthy middle-aged man [15] .
Until now, there have been no data published about the true rate of isolation of H. alvei from clinical specimens, and the clinical significance of this bacterium remains to be defined. Therefore, we performed a study on the frequency of isolation of H alvei from clinical specimens (except stools) and correlated the microbiological findings with the clinical data.
Materials and Methods
Patient evaluation. Patients from whom isolates ofH. alvei were recovered during routine diagnostic testing at the Department of Medical Microbiology, University of Zurich (Zurich) and at the Microbiology Laboratory of the Stadtspital Triemli (Zurich) between January 1992 and May 1995 were identified by reviewing the laboratories' records. The patients' charts were reviewed for data on isolation sites, underlying illnesses, cocultivation of other bacteria, and discrimination between nosocomial infections or community-acquired infections.
Isolation and identification. H. alvei was isolated from normally sterile body fluids such as blood, ascitic fluid, and ab-dominal aspirates as well as from postoperative indwelling catheters, central venous lines, and urine collected from catheters. Respiratory tract isolates were cultured from sputum and tracheal and bronchial aspirates. Samples other than blood were plated on selective and differential media, and colonies of Enterobacteriaceae were detected on MacConkey agar (Becton Dickinson, Basel, Switzerland); blood was cultured with use of the BacT/Alert blood culture system (Organon Teknika, Basel).
The identification of Enterobacteriaceae was based on biochemical data obtained by means of commercial identification systems (API20E and RapID 32E; bioMerieux, Geneva, Switzerland) and on lack of lactose fermentation on MacConkey agar. Biochemical reactions for which H. alvei was positive included lysine decarboxylase, ornithine decarboxylase, and mannitol fermentation, whereas it was negative for fermentation of sorbitol, inositol, sucrose, and melibiose; these negative reactions differentiated H. alvei from Enterobacter aerogenes. Strains with T values of <0.50 and probabilities of identification of <90% in one of the commercial systems were excluded from the study.
Antimicrobial susceptibility testing. Bacteria were tested for susceptibility by the disk diffusion method according to the National Committee for Clinical Laboratory Standards (NCCLS) guidelines. Strains were interpreted as susceptible, intermediately susceptible, or resistant on the basis of the NCCLS criteria. Susceptibilities were compared with use ofthe X 2 test. Strains that were susceptible to ampicillin, amoxicillin/ clavulanic acid, and cephalothin are most likely not part of the genus Hafnia [16] and thus were excluded from the study. We excluded strains of Salmonella and Enterobacter (one each), which were misidentified as H alvei by the commercial systems, by means of these procedures.
We conducted a MEDLINE search with use of the terms Hafnia alvei and Enterobacter hafnia. All reports indexed from December 1966 to August 1995 were evaluated if they presented clinically important information.
Results
Within the 30-month study period H. alvei was isolated from 80 samples collected from 61 patients. Twenty ofthese patients were female, and 41 were male. The mean age for all patients was 55.4 years (range, 13-81 years); the mean age for women was 61.8 years, and that for men was 53.5 years. H alvei was cultured from the respiratory tract 38 times for 35 patients (57.4%), from the gastrointestinal tract 16 times for nine patients (14.8%), and from the urogenital tract 12 times for seven patients (11.5%). The organism was isolated from eight blood cultures of seven patients (11.5%), from three central venous catheters of three patients (3.8%), and from the skin of three patients (3.8%). Table 1 shows the sites of isolation ofH alvei, which was isolated in pure culture of only 20 samples (25%). Organisms cultured concomitantly with H alvei were Enterobacteriaceae, staphylococci, streptococci, and yeasts. None of these microorganisms showed a predilection for association with H. alvei (data not shown).
H. alvei was isolated from 57 patients (93.4%) with underlying illnesses. Twenty (33%) ofthese patients had malignancies: six had leukemia or lymphoma, seven had carcinomas of the abdomen, five had carcinomas of the throat and bronchi, one had a sarcoma, and one had an endometrial carcinoma. Abdominal surgery was performed on 11 (18%) ofthe 61 patients; nine (14.8%) were hospitalized because of trauma; nine (14.8%) underwent heart surgery; four (6.6%) had acute or chronic pancreatitis; three (4.9%) had chronic obstructive pulmonary disease; and one (1.6%) underwent lung transplantation. An underlying disease was not detected in four patients (6.6%). Table 2 shows the isolation sites of H. alvei among patients with underlying illnesses. Eighteen of 35 respiratory isolates were from intubated patients; almost all respiratory isolates from patients who had undergone cardiac surgery (seven of eight isolates) or who were hospitalized because of trauma (four of five isolates) were recovered from intubated patients. None of the patients who had undergone abdominal surgery had isolates of H alvei recovered from respiratory specimens. Overall, 40 patients (66%) infected with H. alvei were intubated, and 19 of them had H. alvei isolated from the respiratory tract.
H. alvei was found to be the sole etiologic agent of invasive disease in three (4.9%) of the 61 patients; two had septicemia due to this organism, and one had peritonitis. All three patients recovered after receiving treatment with imipenem/cilastatin. The clinical characteristics of these three cases are displayed in table 3. H. alvei, together with other organisms, was possibly responsible for two other cases of septicemia and a case of pneumonia.
Ten additional patients in our review received adequate antibiotic coverage for H. alvei, but it was not possible to prove in retrospect that the organism had caused clinically significant infection.
A comparison of the results of antimicrobial susceptibility testing of our strains and those from patients described previously is shown in table 4 . The H alvei strains tested in our study were all susceptible to netilmicin and ciprofloxacin; 99% were susceptible to imipenem and tobramycin; 92% to piperacillin; 90% to co-trimoxazole; 89% to piperacillin/tazobactam; and 88% each to ceftriaxone and ceftazidime.
Discussion
H alvei is rarely considered to be a pathogenic organism. In recent years, case reports of various infections due to H. alvei have been published [1-15, 17, 18] . In our retrospective 30-month study, H. alvei was recovered in 80 specimens from 61 patients. The majority of these patients (93.4%) had a severe underlying condition; this finding supports other reports that H alvei is primarily isolated from patients with NOTE. Twenty (25%) of the isolates were recovered in pure cultures, and 60 (75%) of the isolates were recovered in mixed cultures.
* The following specimens were obtained: tracheal aspirates (16), pharyngeal smears (4), bronchoalveolar lavage fluid (2), nasal smears (1), bronchial aspirates (7), and sputum (8) .
t The following specimens were obtained: ascitic fluid aspirates (2), gallbladder (1), abscesses and deep abdominal wounds (10) , and pancreatic pseudocysts (3); no stool samples were included.
t The following specimens were obtained: urine collected from indwelling catheters (6), clean-catch urine (3), scrotal smears (2), and episiotomy wound (1).
underlying illnesses [11] [12] , except when it is an enteric pathogen [1, 4-6, 8, 17] .
Thirty-eight H alvei isolates were recovered from respiratory specimens, 16 were recovered from the gastrointestinal tract, 12 were recovered from the urogenital tract, eight were recovered from blood, three were recovered from intravenous catheters, and three were recovered from the skin. Only 25% of all H. alvei isolates grew in pure culture. H. alvei was cultured with a variety of other bacteria and fungi in the respiratory and gastrointestinal specimens.
H. alvei was the only identified pathogen causing two cases of septicemia and one case of acute peritonitis. The peritonitis occurred after a patient with stenosis of the choledochus duct underwent endoscopic retrograde cholangiopancreatography, and H. alvei was isolated from his blood and peritoneal fluid. This circumstance indicates that the bacterium's portal of entry NOTE. Only one isolate per patient was taken into account. Of the 61 patients, 35 (18 of whom were intubated) had isolates recovered from the respiratory tract; nine, from the gastrointestinal tract; seven, from blood and central venous catheters; seven, from the urogenital tract; and three, from the skin.
* Total no. of isolates/no. of isolates from intubated patients. t Includes carcinoma (13 patients), acute myelocytic leukemia (3), plasmocytoma (1), non-Hodgkin's lymphoma (1), sarcoma (1), and aplastic anemia of unknown etiology (1) .
t Includes incarcerated hernia (3 patients), perforation of the sigmoid colon (2), small bowel ileus (2), infrarenal aortic aneurysm (2), intra-abdominal abscess (2), delivery of infant by vacuum extraction (1), and endoscopic retrograde cholangiopancreatography (1) .
§ Includes subarachnoidal bleeding (3 patients), polytrauma (2), knife injuries (2), bums (1), femur fracture (1). II Includes aortocoronary bypass surgery (8 patients) and aortic valve replacement (1). might have been the gastrointestinal tract, where it is considered to be a commensal [16] . Earlier reports have also mentioned a correlation between abdominal wounds or abdominal surgery and the isolation of H alvei in blood [10] . H alvei was isolated along with other pathogens from three other patients who had septicemia, pneumonia, and cholangitis. Overall, 11.5% of the patients in our study population had proven (or at least probable) infections caused by H alvei, and 57 of them presented with an underlying illness. Of six patients with H. alvei infections, three had nosocomial infections [19] , and three had community-acquired infections. The number of infections might even have been higher, but the retrospective nature of our study did not allow correlation of the other H alvei isolates with clinically significant infections. However, 10 additional patients from whom H. alvei was isolated were treated with broad-spectrum antibiotics in the absence of a clear diagnosis of infection. This circumstance supports the hypothesis that there was a higher rate of significant infections in our study population. In all six of our patients with proven or probable H. alvei infections, the infections were successfully treated with antibiotics chosen according to the results of susceptibility testing. [6, [16] [17] [18] [19] .
Giinthard and Pennekamp cm 1996; 22 (June) As shown in table 1, 38 (47.5%) of all isolates recovered from 35 patients were of respiratory origin. Eighteen of the patients were intubated at the time that samples were obtained, and 17 were not intubated during their hospital courses. Intubated patients who are immunosuppressed as a result of cardiac surgery or trauma seem to harbor H. alvei in their respiratory tracts more often than do patients who have previously undergone abdominal surgery. Whether the oropharyngeal-tracheal regions of these patients had been colonized previously or whether they became colonized as a result of hospital procedures (e.g., intubation) cannot be answered sufficiently. We do not know the prevalence of H. alvei colonization of the oropharyngeal-tracheal regions and other bodily sites in healthy persons or patients with underlying diseases. In large studies [20] [21] , this bacterium was rarely recovered from any site, making nosocomial infection improbable and emphasizing the likelihood of endogenous colonization in most patients before admission to the hospital.
On the other hand, only eight of 30 respiratory tract isolates were recovered from pure cultures, compared with 22 isolates that were recovered from mixed cultures; these mixed cultures mainly consisted of other gram-negative bacteria that are known to colonize the oropharyngeal-tracheal tract in severely ill patients [22] . The presence of H. alvei in feces reflects the fact that the organism is part of the normal bowel flora. Case reports of H. alvei as the etiologic agent of diarrhea must be evaluated critically because no toxin production or toxic mucosal changes in humans have been detected so far. However, it is worth mentioning that H. alvei might cause diarrhea in immunocompromised patients, as case reports of neonates and malnourished children with diarrhea have shown [1, 7, 17] .
In comparing the susceptibilities of H. alvei isolates, we observed a higher rate of susceptibility to ampicillinJamoxicillin and cephalothin among the strains described in the literature. In conducting this study we used susceptibility to amoxicillin and first-generation cephalosporins as selection criteria; therefore, these data are not comparable to those from previous reports.
In our study the most active antimicrobials were netilmicin (100% of isolates were susceptible), ciprofloxacin (100% susceptible), and imipenem (99% susceptible). These results are similar to the scant results reported in the literature (only a few strains have been tested), where 100% of the H. alvei strains were found to be susceptible to amikacin, gentamicin, ciprofloxacin, and imipenem [23 -26] .
The susceptibility to ceftazidime observed in our study was significantly different from that reported in the literature (P < .001). This difference cannot be explained but is probably not caused by the larger number of strains tested in our study because the results were otherwise almost congruent. Another slight difference was observed when susceptibilities to piperacillin were compared: 92% of our strains (64 tested) were susceptible, while 85% of strains in other reports (13 tested) were susceptible. However, the fact that susceptibility results from other reports as well as from our study were comparable for most antimicrobials and that the biochemical features were similar indicates that H. alvei was correctly identified as the pathogen.
In summary, this study shows that H. alvei is a rare human pathogen; however, the organism may be responsible for serious nosocomial and community-acquired infections. Infections mainly occur in patients with underlying illnesses, and H. alvei is often isolated in coculture with different gram-negative rods, which may be due to endogenous colonization of the bowel. Treatment of H. alvei infection on the basis of antimicrobial susceptibility testing results is effective. In severe cases, treatment with imipenem or a third-generation cephalosporin in combination with an aminoglycoside is recommended. More data on the role of H. alvei and its pathogenicity are needed. In addition, the colonizing rate for this organism in different sites in healthy adults must be determined.
